Lv52
960 积分 2024-06-21 加入
Pharmacological Targeting of IRF4 As a Therapeutic Strategy for Multiple Myeloma
27天前
已完结
The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity
3个月前
已完结
Food effect trial of the pharmacokinetics and safety of TQ05105 in healthy Chinese subjects
3个月前
已完结
Discovery of Potent and Orally Effective Dual Janus Kinase 2/FLT3 Inhibitors for the Treatment of Acute Myelogenous Leukemia and Myeloproliferative Neoplasms
4个月前
已完结
The Pharmacokinetics, Pharmacodynamics, and Safety of Orally Dosed INCB018424 Phosphate in Healthy Volunteers
5个月前
已完结
The allosteric inhibitor ABL001 enables dual targeting of BCR–ABL1
5个月前
已完结
Discovery of novel BCR-ABL PROTACs based on the cereblon E3 ligase design, synthesis, and biological evaluation
7个月前
已完结
A kinase-independent Bcr-Abl function mediating an Hsp70-Bim protein-protein interaction in chronic myeloid leukemia
7个月前
已完结
MTAP deficiency confers resistance to cytosolic nucleic acid sensing and STING agonists
8个月前
已完结
Novel in Vivo and in Vitro Pharmacokinetic/Pharmacodynamic-Based Human Starting Dose Selection for Glofitamab
8个月前
已完结
皖公网安备34019202002308
